Biotinylated Human CTLA-4/CD152 Protein (LTP11016)

Product Name
Biotinylated Human CTLA-4/CD152 Protein (LTP11016)
Catalog Number
LTP11016
Quantity
100ug
Price
$450 In stock
Background
CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), also known as CD152, is a protein receptor that, functioning as an immune checkpoint, downregulates immune responses.CTLA4 is constitutively expressed in regulatory T cells but only upregulated in conventional T cells after activation – a phenomenon which is particularly notable in cancers. It acts as an "off" switch when bound to CD80 or CD86 on the surface of antigen-presenting cells.
Description
Recombinant Biotinylated Human CTLA-4 Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal. It contains Lys36-Asp161.
Target
CTLA-4/CD152
Species
Human
Gene/Protein ID
P16410
Exact Sequence
Lys36-Asp161
Molecular Weight
The protein has a predicted MW of 16.3 kDa. Due to glycosylation, the protein migrates to 25-30 kDa based on the Tris-Bis PAGE result.
Activity
Immobilized Anti-CTLA-4 Antibody, hFc Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human CTLA-4, His Tag with the EC50 of 45.7ng/ml determined by ELISA (QC Test). See testing image for detail.
Tag
C-His-Avi
Express System
Expi293
Purity
> 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
Endotoxin
Less than 1EU per ug by the LAL method.
Formulation
Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as a protectant before lyophilization.
Stability and Storage

Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

Shipping
Shipped at ambient temperature.
Reconstitution

Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

Image
Biotinylated Human CTLA-4/CD152 Protein (LTP11016)
  • 5 Units in Stock
Ask a Question

$450.00

Add to Cart: